We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.57B
1-Year Est. Return 37.84%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+37.84%
3 Year Est. Return
+124.17%
5 Year Est. Return
+158.09%
10 Year Est. Return
+485.17%
AUM
$691M
AUM Growth
+$89.6M
Cap. Flow
+$70.8M
Cap. Flow %
10.23%
Top 10 Hldgs %
16.9%
Holding
565
New
53
Increased
300
Reduced
124
Closed
26

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$4.05M
2
AAPL icon
Apple
AAPL
+$2.61M
3
OKE icon
Oneok
OKE
+$2.54M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.19M
5
AMZN icon
Amazon
AMZN
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 15.08%
2 Energy 14.06%
3 Industrials 11.94%
4 Technology 9.74%
5 Miscellaneous 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$648B
$16.5M 2.39%
126,785
+16,504
+15% +$2.19M
XOM icon
2
ExxonMobil
XOM
$667B
$14.4M 2.09%
176,308
+25,794
+17% +$2.05M
AAPL icon
3
Apple
AAPL
$4.85T
$12.9M 1.86%
334,380
+67,368
+25% +$2.61M
PG icon
4
Procter & Gamble
PG
$341B
$12.3M 1.78%
135,738
+14,261
+12% +$1.3M
T icon
5
AT&T
T
$175B
$11.4M 1.65%
384,155
+55,951
+17% +$1.59M
GE icon
6
GE Aerospace
GE
$329B
$10.8M 1.56%
93,072
+10,227
+12% +$1.24M
MSFT icon
7
Microsoft
MSFT
$3.69T
$10.2M 1.47%
136,915
+19,834
+17% +$1.45M
PEP icon
8
PepsiCo
PEP
$182B
$9.93M 1.44%
89,131
+12,083
+16% +$1.4M
VZ icon
9
Verizon
VZ
$204B
$9.71M 1.4%
196,080
+29,858
+18% +$1.4M
CVX icon
10
Chevron
CVX
$414B
$8.66M 1.25%
73,341
+12,834
+21% +$1.4M
EPD icon
11
Enterprise Products Partners
EPD
$82.8B
$8.31M 1.2%
319,218
+11,685
+4% +$309K
JPM icon
12
JPMorgan Chase
JPM
$923B
$7.71M 1.12%
80,667
+20,708
+35% +$1.91M
DD icon
13
DuPont de Nemours
DD
$17.4B
$7.41M 1.07%
42,246
+24,257
+135% +$4.05M
PFE icon
14
Pfizer
PFE
$158B
$7.05M 1.02%
207,974
+15,009
+8% +$482K
INTC icon
15
Intel
INTC
$580B
$6.44M 0.93%
169,291
+38,108
+29% +$1.35M
MMP
16
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.42M 0.93%
90,334
+543
+0.6% +$37.5K
RTX icon
17
RTX Corp
RTX
$261B
$6.27M 0.91%
85,660
+18,326
+27% +$1.36M
PMD
18
DELISTED
Psychemedics Corporation
PMD
$6.22M 0.9%
337,060
+19,763
+6% +$435K
MRK icon
19
Merck
MRK
$361B
$6.16M 0.89%
100,929
+22,740
+29% +$1.38M
AMGN icon
20
Amgen
AMGN
$206B
$5.6M 0.81%
29,988
+1,428
+5% +$253K
BP icon
21
BP
BP
$117B
$5.27M 0.76%
151,803
-14,654
-9% -$466K
BMY icon
22
Bristol-Myers Squibb
BMY
$130B
$5.12M 0.74%
80,309
+4,195
+6% +$245K
CVS icon
23
CVS Health
CVS
$117B
$4.85M 0.7%
59,851
+6,715
+13% +$531K
ETN icon
24
Eaton
ETN
$160B
$4.79M 0.69%
62,275
+14,444
+30% +$1.09M
MMM icon
25
3M
MMM
$84.3B
$4.76M 0.69%
27,113
+6,696
+33% +$1.16M

Similar funds

Moors & Cabot's Q3 2017 Portfolio in Review

As of Q3 2017, Moors & Cabot held 565 positions worth $691M, up 15% from $602M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Moors & Cabot deployed $70.8M of net new capital in Q3 2017, opening 53 new positions and adding to 300 existing holdings. Its largest new stake was Oneok: 47,060 shares worth $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was General Mills, an estimated $799K trimmed.

  • Moors & Cabot's largest Q3 2017 buy was Oneok: 47,060 shares worth $2.61M.
  • Moors & Cabot added most to DuPont de Nemours in Q3 2017, an estimated $4.05M increase.
  • Moors & Cabot's biggest Q3 2017 reduction was General Mills, cutting an estimated $799K.
  • Moors & Cabot fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $3.97M.
  • Moors & Cabot's ten largest holdings make up 17% of its $691M portfolio in Q3 2017.
  • Moors & Cabot opened 53 new positions and closed 26 in Q3 2017.
  • Moors & Cabot's portfolio value rose 15% quarter-over-quarter to $691M.

Based on Moors & Cabot's 13F filing for Q3 2017, filed 16 Nov 2017.